POCI vs. LNSR, PDEX, RCEL, AVR, INFU, LAKE, PTHL, LUCD, LUNG, and OBIO
Should you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include LENSAR (LNSR), Pro-Dex (PDEX), Avita Medical (RCEL), Anteris Technologies Global (AVR), InfuSystem (INFU), Lakeland Industries (LAKE), Pheton (PTHL), Lucid Diagnostics (LUCD), Pulmonx (LUNG), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry.
Precision Optics vs. Its Competitors
Precision Optics (NASDAQ:POCI) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.
In the previous week, Precision Optics and Precision Optics both had 1 articles in the media. Precision Optics' average media sentiment score of 0.00 equaled LENSAR'saverage media sentiment score.
Precision Optics has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500.
Precision Optics has a net margin of -32.84% compared to LENSAR's net margin of -99.17%. Precision Optics' return on equity of -54.03% beat LENSAR's return on equity.
Precision Optics has higher earnings, but lower revenue than LENSAR. Precision Optics is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two stocks.
13.7% of Precision Optics shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 13.0% of Precision Optics shares are held by company insiders. Comparatively, 38.5% of LENSAR shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
LENSAR has a consensus target price of $15.00, suggesting a potential upside of 13.73%. Given LENSAR's stronger consensus rating and higher probable upside, analysts clearly believe LENSAR is more favorable than Precision Optics.
Summary
LENSAR beats Precision Optics on 8 of the 13 factors compared between the two stocks.
Get Precision Optics News Delivered to You Automatically
Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Precision Optics Competitors List
Related Companies and Tools
This page (NASDAQ:POCI) was last updated on 7/3/2025 by MarketBeat.com Staff
